GlaxoSmithKline to pay $63.8 million Paxil settlement

Share this article:
GlaxoSmithKline said it will pay $63.8 million to settle a lawsuit involving the promotion of its antidepressant Paxil. Glaxo denied the lawsuit’s claims that it promoted Paxil for use in children and adolescents while withholding negative information about the drug’s safety but decided on a settlement to stave off further litigation costs. Though considered safe for adults, the FDA has issued warnings against use of Paxil in children after studies found the drug increased suicidal tendencies while having questionable effects on depression. Under the settlement, plaintiffs in the class action lawsuit could get full refunds for their purchases of Paxil or Paxil CR if they have documentation of their purchases. Those without purchase records could be entitled to a $15 refund. A judge will conduct a hearing on March 9 to decide whether the settlement is fair and whether the plaintiff’s attorneys are entitled to the $16 million settlement fee they are requesting.
Share this article:

Email Newsletters

More in News

Star Group merges with Vox Medica, Calcium NYC

Star Group merges with Vox Medica, Calcium NYC

The newly formed group will be known as Calcium with Steve Michaelson, formerly of Rosetta Wishbone, at the helm.

Survey finds pay doesn't make doctors happy

Survey finds pay doesn't make doctors happy

Medscape's survey of over 24,000 physicians found that a paycheck is not necessarily linked to a physician's professional satisfaction.

CDC sees declines in some diabetes complications

CDC sees declines in some diabetes complications

Centers for Disease Control data shows that diabetes complications including heart attack and amputation fell in the twenty years between 1990 and 2010. The bad news: the number of diagnosed ...